Relative Effects of Barrier Precautions and Topical Antibiotics on Nosocomial Bacterial Transmission: Results of Multi-compartment Models by Boldin, B. et al.
Bulletin of Mathematical Biology (2007) 69: 2227–2248
DOI 10.1007/s11538-007-9205-1
ORIGINAL ARTICLE
Relative Effects of Barrier Precautions and Topical
Antibiotics on Nosocomial Bacterial Transmission:
Results of Multi-compartment Models
B. Boldina,∗, M.J.M. Bontenb,O .D i e k m a n n a
aDepartment of Mathematics, University of Utrecht, Budapestlaan 6, 3584 CD Utrecht,
The Netherlands
bDepartment of Internal Medicine, Division of Infectious Diseases, University Medical
Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
Received: 5 December 2006 / Accepted: 22 February 2007 / Published online: 24 April 2007
© Society for Mathematical Biology 2007
Abstract Nosocomial bacterial infections in critically ill patients are generally preceded
by asymptomatic carriage (i.e. colonization) at one, or even several, body sites such as
the skin, the gastro-intestinal and the respiratory tract. Different routes of transmission
between the colonized sites create a complex epidemiology, which is additionally com-
plicated by the smallness of the patient population size and the rapid patient turnover,
characteristic for intensive care units (ICUs). Naturally occurring large ﬂuctuations in the
prevalence of colonization make it very difﬁcult to determine the efﬁcacy of control mea-
sures that aim to reduce the prevalence of antibiotic-resistant bacteria in ICUs. Theoretical
models can sharpen our intuition through carefully designed thought experiments. In this
spirit, we introduce and investigate two models that incorporate the fact that patients may
be colonized at multiple body sites. Our study can be applied to several pathogens com-
monly found in ICUs, such Pseudomonas Aeruginosa, enteric Gram-negative bacteria,
MRSA and enterococci. We evaluate the effects of barrier precautions (improved hygiene,
use of gloves and gowns, etc.) and of administration of nonabsorbable antibiotics on the
prevalence of colonization in ICUs and ﬁnd that the effect of the controversial, though
widely used, antibiotic prophylaxis can only be substantial if the patient-to-patient trans-
mission has already been reduced to a subcritical level by barrier precautions. Taking into
account that the very use of antibiotics may increase the selection for resistant strains and
may thereby only add to the ever increasing problem of antibiotic resistance, our ﬁndings
hence representaﬁrmtheoretical argumentagainst theroutineuseoftopical antimicrobial
prophylaxis for infection control.
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1. Introduction
Infections with antibiotic-resistant microorganisms frequently occur in critically ill pa-
tients. In almost all cases, infection is preceded by asymptomatic carriage, i.e., coloniza-
tion. Although different pathogens have different preferential colonization sites, several
body sites may eventually become colonized, even those that are protected in healthy in-
dividuals. After one week of hospitalization, colonization of the respiratory tract, gastro-
intestinal tract and skin with potentially pathogenic microorganisms occurs in almost all
critically ill patients (Bonten et al., 1996).
Intensive care units (ICUs) generally hold a small number of patients (typically 5–50),
with an average length of stay that may very well be less than one week. Several routes
of initiation of colonization can be distinguished. Patients may become colonized during
their stay in the ICU through cross-transmission, a process that depends on the colo-
nization pressure, i.e., the number/proportion of other patients already being colonized
(Bonten et al., 1998). In some patients, susceptible microorganisms develop antibiotic
resistance, either through speciﬁc mutations or through horizontal transfer of resistance
genes. These events usually occur under antibiotic exposure and this mode of acquisition
of resistance has been labeled endogenous acquisition of resistance. Finally, patients may
be admitted to an ICU while being colonized, either at a level that is detectable by micro-
biological cultures, or in bacterial amounts that do not (yet) exceed the detection limits
of sampling tests. In the latter case, selection through antibiotics may ultimately reveal
‘new’ cases of colonization. The smallness of ICU populations, rapid patient turnover and
different routes of transmission create a complex epidemiology, with naturally occurring
large ﬂuctuations in the prevalence of colonization (Bonten et al., 2001).
Several infection control strategies can be used to reduce the prevalence of coloniza-
tion in such a setting. Barrier precautions (e.g. hand disinfection, use of gloves and gowns,
isolation of patients) aim to reduce cross-transmission (i.e. patient-to-patient transmis-
sion) and, although to a much smaller extent, endogenous transmission (transmission of
microorganisms from one patient’s body part to another, as yet uncolonized, part).
Administration of antibiotics, on the other hand, has many different facets. When ad-
ministered intravenously or topically, antibiotics may serve as a way to reduce the preva-
lence of colonization in ICUs, either by reducing or by completely eradicating the suscep-
tible ﬂora, thereby also preventing the development of resistance (de Jonge et al., 2003;
van Saene et al., 2003). Yet, the very use of antibiotics may also increase the selection
pressure and the emergence of resistant strains and thereby only adding to the ever in-
creasing problem of antibiotic resistance.
Enteral administration of nonabsorbable antibiotics, as done in selective decontam-
ination of the digestive tract (SDD), is highly controversial: topical intestinal applica-
tion of nonabsorbable antibiotics in ICU patients was part of a successful strategy to
control an outbreak of multi-resistant Gram-negative bacteria in a French ICU (Brun-
Buisson et al., 1989), but was associated with increased resistance in some other ICUs
(Lingnau et al., 1997; Verwaest et al., 1997). In all successful interventions, SDD was
presumably instrumental in reducing the spread in the ICU (de Jonge et al., 2003;
van Saene et al., 2003). However, in all such interventions barrier precautions and antibi-
otic use were introduced simultaneously, but the relative importance of the two control
measures has never been determined.Relative Effects of Barrier Precautions and Topical Antibiotics 2229
We hence developed a theoretical setting to investigate the relative effects of different
interventions on the prevalence of colonization in ICUs. The small population sizes and
rapid patient turnover that are typical for intensive care units, make it natural to formulate
and study a stochastic model. But for precisely the same reasons, one needs to be very
careful when drawing conclusions regarding the efﬁcacy of different control measures.
Namely, if we implement a certain intervention for some time and this intervention ap-
pears to be successful, to what extent is the reduction of colonization a result of random
ﬂuctuations and to what extent is it a result of the control measure? We therefore also
formulated a deterministic counterpart of the stochastic model and compared the conclu-
sions regarding the relative effects of different interventions with the ones drawn from the
Markov chain model.
We present both models and the results in Sections 3 and 4. But to begin with, we now
ﬁrst describe the epidemiology and patient dynamics in intensive care units.
2. The epidemiology and the dynamics in the ICU
Our study does not focus on any pathogen in particular. The microorganism we have
in mind is characterized by the following properties: it is a pathogen widely found in
ICUs, it can colonize several sites of a patient’s body (including the gastro-intestinal
tract) and is resistant to some antibiotics, but susceptible to the intestinally adminis-
tered nonabsorbable antibiotics. Pseudomonas aeruginosa, enteric Gram-negative bacte-
ria, methicillin-resistant Staphylococcus aureus (MRSA) and enterococci are all examples
of such a pathogen.
We shall, however, single out three body sites that can become colonized: the skin, the
gut and the lungs, and label the patients in the ICU according to the parts of their bodies
that are colonized at the time. Each of the body sites is assumed to be either colonized or
not (in other words, we neglect the fact that individuals may differ in the bacterial load
they carry at various sites) and so the label GS, for example, indicates that an individual
is colonized in the gut and on the skin, but not (yet) in the lungs. In this way we can at any
point in time characterize each patient in the ICU by one of the following eight labels: 0,
G, S, L, GS, GL, SL, GSL.
Skin colonization may lead to contamination of the health care workers’ hands during
patient care and is a prerequisite for cross-transmission. We shall use the term “skin col-
onization” throughout the paper and describe by this term any situation that may lead to
cross-transmission (e.g. a contaminated respiratory tubing system or suffering from diar-
rhea). In fact, colonization of the lungs/intestines is characterized as one that cannot be
transmitted through contaminated hands. It is, however, possible that a patient colonized
in the lungs or in the gut transmits the bacteria to the skin by endogenous transmission.
The lungs, the gastro-intestinal tract and the skin are certainly sites frequently col-
onized by one or even several pathogens in ICUs (Bonten et al., 1996). But more im-
portantly, these three sites capture precisely the three substantially different manners of
colonization in view of the possible control measures: patients colonized on the skin are
infectious and hence an immediate threat to other patients (and health care workers). We
can reduce this threat by applying barrier precautions. Patients colonized in the gut/lungs
are not yet infectious but may become so through endogenous transmission (e.g. devel-
oping diarrhea or having a respiratory tube inserted) and while reducing the chance of2230 Boldin et al.
bacteria spreading from the gut to the skin can be achieved by barrier precautions as well
as antibiotics, preventing the bacteria to spread from the lungs to the skin can only be done
by improved hygiene. These three body sites hence capture the essence and any additional
colonization site would mainly only complicate the notation as well as the computations
without adding new qualitative aspects.
2.1. Transmission
We have already indicated in the previous subsection the possible transmission routes.
Here we describe them again in order to also introduce the notation and some additional
assumptions. We distinguish the following transmissions:
1. Cross-transmission, meaning that a patient colonized on the skin transmits the infec-
tion,viahealth care workers,toanotherpatient’s skin.Allindividualsnotyetcolonized
on the skin are assumed to be equally susceptible to an infection (i.e. possible colo-
nization of other body sites does not inﬂuence their susceptibility). Infectiousness of
patients colonized on the skin is assumed to be independent of the colonization status
of their other parts. We denote the (constant) rate at which an individual colonized (at
least) on the skin infects type 0, G, L, GL by β.
2. Endogenous transmission, where a patient spreads the bacteria from one of the colo-
nized sites to one of its as yet uncolonized parts. The following internal transmissions
are possible:
– From the gut to the skin
– From the skin to the gut or to the lungs
– From the lungs (possibly via the respiratory tube) to the skin
The list of all possible endogenous transmissions and the (constant) rates at which they
occur is as follows:
G
αGS −→ GS, GL
αGS −→ GSL,
L
αLS −→ SL, GL
αLS −→ GSL,
S
αSG −→ GS, SL
αSG −→ GSL,
S
αSL −→ SL, GS
αSL −→ GSL.
2.2. Admission of new patients
Individuals are admitted to the ICU at a constant rate λ. Newly admitted patients can
be colonized at any of the three body parts. We shall assume that the probabilities with
which a newly admitted individual is of a certain type are constant in time (one can for
example imagine that the prevalence of this pathogen in the community at large is station-
ary, and that the individuals admitted to the ICU are sampled randomly from the outside
community) and we denote them by p0, pG, pS, pL, pGS, pGL, pSL and pGSL and require
that
p0 +pG +pS +pL +pGS +pGL +pSL +pGSL = 1.Relative Effects of Barrier Precautions and Topical Antibiotics 2231
2.3. Discharge/death
Individuals are removed from the ICU (either due to discharge or death) with constant
probability per unit of time μ, which is independent of the patient’s colonization status.
The numbers λ and μ are related to each other via the size N∗ of the ICU as follows:
λ = μN∗ (see Appendix A).
3. The modeling
The typically low number of patients in ICUs makes a stochastic model a more suitable
and natural description of the process than a deterministic one. We shall nevertheless ﬁrst
formulate a deterministic model (for the reasons mentioned in the Introduction) and then
later on compare some of its features to the results of the simulations of the stochastic
version of the model.
3.1. The deterministic model
If the population sizes were large, we could describe the dynamics in the ICU by the
following set of ordinary differential equations:
˙ x0 = μp0 −(σI +μ)x0,
˙ xG = μpG −(σI +αGS +μ)xG,
˙ xS = μpS +σIx0 −(αSG +αSL +μ)xS,
˙ xL = μpL −(σI +αLS +μ)xL,
˙ xGS = μpGS +(σI +αGS)xG +αSGxS −(αSL +μ)xGS,
˙ xGL = μpGL −(σI +αGS +αLS +μ)xGL,
˙ xSL = μpSL +(σI +αLS)xL +αSLxS −(αSG +μ)xSL,
˙ xGSL = μpGSL +(σI +αLS +αGS)xGL +αSLxGS +αSGxSL −μxGSL.
(1)
Here, xj with j ∈{ 0,G,S,L,GS,GL,SL,GSL} represent the fractions of the corre-
sponding subpopulations (indicated by the indices) and
I = xS +xGS +xSL +xGSL (2)
denotes the fraction of individuals that are colonized on the skin and can hence (immedi-
ately) cause new cases of colonization. The new parameter σ can be expressed in terms
of the ‘old’ ones as σ =
βλ
μ .
The system (1) is a scaled version of the one written in terms of actual numbers (as
opposed to fractions) and the interested reader can ﬁnd all the details in Appendix A.
For reader’s convenience we present the possible changes in an individual’s colonization
status and the rates at which they occur also in the form of a diagram (see Fig. 1).2232 Boldin et al.
Fig. 1 Dynamics of an individual’s colonization status.
3.1.1. Equilibria and their stability
In Appendix A we show that the equilibrium value of I is obtained as a ﬁxed point of the
function F given by
F(I)= p +
p0σI
σI+μ
+
pL(σI +αLS)
σI+αLS +μ
+
pG(σI +αGS)
σI+αGS +μ
+
pGL(σI +αGS +αLS)
σI+αGS +αLS +μ
. (3)
where
p = pS +pGS +pSL +pGSL. (4)
When F(0)>0, the system (1) has a unique positive equilibrium and this equilibrium is
locally asymptotically stable.
In the case F(0) = 0 (for instance, when all newly admitted individuals are free of the
infectious agent in question, i.e., p0 = 1), the system admits a ‘disease free’ equilibrium,
by which we mean an equilibrium consisting of only the subpopulations that cannot cause
new infections. Whether the system also admits a nontrivial steady state, relies on the
value of the basic reproduction ratio R0 (Diekmann and Heesterbeek, 2000), which is in
the case F(0) = 0 well deﬁned and is equal to σ
μ. Indeed, if, for instance, p0 = 1( s e e
Appendix A for the derivation of R0 for other cases in which F(0) = 0) and one skin
infected individual is introduced into an otherwise infection free ICU, then this individual
is expected to remain in the ICU for 1
μ units of time and is in this time expected to infect
the skin of σ·1
μ patients.
If R0 < 1 the infection free steady state is the only steady state and it is locally stable.
When R0 > 1 there exists also a unique nontrivial equilibrium, which is then locally
stable, while the infection free steady state is in that case unstable.
The proof of these claims is rather technical and can be found in Appendix A.
3.2. The discrete time Markov chain model
Inadditiontothedeterministicmodel,weformulatedadiscretetimeMarkovchainmodel,
which we investigated by way of simulations. The outcomes of simulations will be pre-
sented later on, here we only brieﬂy describe the setting.Relative Effects of Barrier Precautions and Topical Antibiotics 2233
In all the simulations, the reported ICU is assumed to hold 20 beds, all of which were
assumed to be occupied at all times. The process was simulated as a discrete time process,
taking one day as the unit of time. We have in fact simulated the process for a number of
different choices of ICU size. We found that, even though the outcomes (say, colonization
levels) are different, our main conclusions do not rely on the size of the intensive care
unit.
The epidemiology (i.e. the colonization sites and the transmission routes) has already
beendescribed inSection 2.Wenowfurthermoreassumethatthedischargeandadmission
take place at one particular time each day. In this way, the only thing that changes in the
ICU in the course of one day are the patients’ colonization statuses.
The length of stay of each patient in the ICU is taken to be geometrically distributed
with parameter μ. After the discharge has taken place, the available beds are immediately
ﬁlled with new patients. The colonization statuses (i.e. labels) of newly admitted patients
are distributed according to the admission probabilities pj. The endogenous transmissions
are taken to be geometrically distributed with constant rates already introduced in Sec-
tion 2. Patient-to-patient transmission, on the other hand, is a density dependent process.
The cross-transmission rate is proportional to the number of patients in the ICU that are
colonized on the skin and is given by
σ ×the number of patients colonized on the skin
the number of patients in the ward−1
.
Since this rate may change in time, we update it on a daily basis, after each round of
discharge and admission. Furthermore, transmissions are assumed to be independent of
one another.
4. Infection control measures
Administration of topical, nonabsorbable antibiotics has no effect on the colonization of
the skin or the lungs. It can, however, have two different effects on the individual’s gastro-
intestinal tract: (i) it either reduces the rate of endogenous transmission of bacteria from
the gut to the skin (although bacterial loads were not explicitly included, one can imag-
ine that the lower rate is a result of the reduction in the bacterial load due to antibiotic
therapy), but the patient remains colonized until discharge, or, (ii) colonization can be
completely eradicated before the patient leaves the ICU. Both of these scenarios were in-
vestigated but since the outcomes were very similar we shall only present the results of the
former scenario. Let us only remark that the latter requires a modiﬁcation of both models
to take into account the possibility that the intestinal carriage is successfully eliminated
during patient’s ICU stay.
Barrier precautions, on the other hand, can have an effect on several parameters. Pri-
marily, they aim to reduce the cross-transmission parameter σ, but improved hygiene
during patient care may also lower the rates αLS and αGS. Furthermore, isolation of pa-
tients on admission or disinfection of a patient’s skin on admission may lower the value
of p = pS +pGS +pSL +pGSL.
In the deterministic setting we were in particular interested in the sensitivity of the
equilibrium value of skin colonizations, I∗, to different parameters. The steady state value2234 Boldin et al.
of I is given implicitly as a ﬁxed point of the function F (see also Appendix A), given
in (3).
The sensitivity of I∗ to a certain parameter, say θ,
SI∗,θ =
∂I∗
∂θ
can be determined by using the implicit function theorem as
SI∗,θ =
∂F
∂θ
1− ∂F
∂I∗
,
but since explicit computations lead to very cumbersome expressions that do not offer
straightforward ways of comparing the sensitivities of I∗ to different parameters, we pro-
ceed with numerical examples.
We performed a series of numerical experiments for both models, aiming to deter-
mine the relative importance of different interventions. In particular, we tried to identify
circumstances in which antibiotic therapy has a substantial effect and should be used to
reduce the prevalence of colonization in an ICU. In the next section we present a cou-
ple of representative ﬁgures, along with the interpretation and the conclusions concerning
implementation of control measures in ICUs. Some additional ﬁgures can be found in
Appendix B.
4.1. Results
In reality some parameters, such as the discharge rate μ and the fraction of skin coloniza-
tions on admission p, are difﬁcult to inﬂuence. We will therefore keep μ and p constant
in the examples presented in this section, taking the same values for the deterministic and
the stochastic model: μ = 0.1, p = 0.2. The reader can ﬁnd some additional ﬁgures, in
which the effects of reducing p (which would correspond either to increased isolation on
admission of patients that are colonized on the skin or to improved hygiene on admission)
are displayed, in Appendix B (see Figs. B.2, B.3).
Studying the deterministic model, we found that the efﬁcacy of topical antimicrobial
prophylaxis relies heavily on (i) the level of cross-transmission in the ICU and (ii) the
proportion of individuals that are colonized in the gut on admission. This can be seen
from Fig. 2 in which three scenarios are presented; (a) low, (b) intermediate and (c) high
level of intestinal colonization on admission:
(a) In Fig. 2a, the percentage of individuals that are colonized in the gut on admission is
very low (15%, including 5% of the total that are also already colonized on the skin).
In this case, antibiotic prophylaxis may, of course, be beneﬁcial on an individual level,
but has virtually no effect on the endemic level of skin colonizations, regardless of the
level of cross-transmission in the ICU.
(b) In Fig. 2b, the proportion of individuals that carry the pathogen in the gut on ad-
mission is 35%, including 5% of the total that are also colonized on the skin. Here,
reducing αGS to zero has again almost no effect on I∗ when the level of cross trans-
mission in the ICU is high (i.e. when (1−p)σ/μ>1; see the top two lines), but when
the cross-transmission rate is reduced so that on average the patients are not expectedRelative Effects of Barrier Precautions and Topical Antibiotics 2235
Fig. 2 I∗ plotted as a function of αGS. In all three ﬁgures μ = 1
10, αLS = 1
2 and, from the top to the
bottom, σ = 1
2, 1
5, 1
8, 1
10, 1
20, 1
50,0 .I n( a )pj = 0.05 for j  = 0, (b) pG = 0.2, pGL = 0.1, pj = 0.05 for
j  ={ 0,G,GL} a n di n( c )pG = 0.5, pGL = 0.2, pj = 0.05 for j  ={ G,GL}.
to transmit the infection to another patient during their stay in the ICU (the bottom
lines),antibiotic prophylaxisstartsto havean effecton I∗.Inthecase σ = 0 (i.e.when
there is no patient-to-patient transmission at all in the ward), antibiotic treatment has
the capacity to reduce the prevalence of colonization by about a third (prevalence is
reduced from 50% to 35%; see the bottom curve in Fig. 2b).
(c) Antibiotic prophylaxis can only really be beneﬁcial on a population level when a
large proportion of patients is amenable for treatment. However, even then, the level
of cross-transmission in the ICU determines the efﬁcacy of antibiotics. We observe
from Fig. 2c that even though as much as 70% of the newly admitted patients are
colonized in the gut on admission (and not yet on the skin), reducing αGS to zero
has almost no effect on I∗ when (1 − p)σ/μ > 1 (see the top line in Fig. 2c; the
prevalence is reduced for only about a ﬁfth when αGS is pushed to zero). Only when
(1 − p)σ/μ is brought below one (by applying barrier precautions), do antibiotics
start to have an effect on the endemic level of skin colonizations and in such a case
we can observe a two-fold reduction in I∗ (bottom three lines).
Figure 2 also demonstrates the sensitivity of I∗ to the cross-transmission parameter σ.
We see from Figs. 2a, b that, while antibiotics have practically no effect on the endemic
level of skin colonizations, barrier precautions that aim to reduce σ have the potential to
cause a two or even three-fold reduction in the prevalence: in Fig. 2a, the prevalence is
reduced from 85% to 30%, regardless of the value of αGS, while in Fig. 2b the reduction
is on average 45%.
Only in the case when the proportion of individuals colonized in the gut on admission
and the risk of transmitting the infection from the gut to the skin are high (Fig. 2c) can the
antibiotics signiﬁcantly reduce the prevalence of skin colonizations in the ICU. But, as
mentioned before, the level of cross-transmission has to be reduced ﬁrst. In such a case,
therefore, a combination of the two control measures would bring the best results.
A similar experiment was performed taking αLS = 1
15 (and so, while in the scenario
depicted in Fig. 2 the patients are expected to transmit the bacteria from the lungs to the
skin during their stay in the ICU, they are not expected to do so when αLS = 1
15). The2236 Boldin et al.
Fig. 3 pj = 0.05 for j  = 0, αSG = 0.5, αLS = 0.5, αSL = 0.2. In (a) σ = 1a n dαGS = 1 (black),
αGS = 0.1 (dark grey), αGS = 0.01 (light grey). In (c) σ = 0.01 and αGS = 1 (black), αGS = 0.1( d a r k
grey), αGS = 0.01 (light grey). The right columns (ﬁgures (b) and (d)) show the mean of 1000 simulations,
corresponding to αGS = 0.01, along with the shaded area containing 90% of the simulations, and the result
of a single simulation.
results are very similar to the ones in Fig. 2 and will not be shown here, but the interested
reader can ﬁnd them in Appendix B (Fig. B.1).
We now shift our attention to the results of the simulations. In all the ﬁgures presented
here, the process was simulated 1000 times for a period of 200 days, starting with a ran-
domly chosen initial condition. Just as in the deterministic case, we study three scenarios
of intestinal colonization on admission: in Fig. 3 the proportion of individuals admitted
with colonized gut is low, in Fig. 4 it is intermediate and it is high in Fig. 5.
The left columns (Figs. 3a, c, 4a, c and 5a, c) show the mean of 1000 simulations for
three values of the endogenous rate αGS.
The right columns (Figs. 3b, d, 4b, d and 5b, d) contain the bottom curve of the left
column (i.e. the one corresponding to the lowest αGS), the result of a single simulation
and also a shaded grey area corresponding to the area containing 90% of all simulations.
The simulations support the conclusions obtained from the deterministic model: when
the admission of intestinal colonizations to the ICU is low (Fig. 3), antibiotic prophy-
laxis has almost no effect on the mean level of the prevalence, regardless of the level of
cross-transmission in the unit. This is also the case when the admission of intestinal colo-
nizations is somewhat higher (see the top row in Fig. 4). However, lowering the rate αGS
does start to have an effect on the mean prevalence if the cross-transmission is reduced to
almost zero (see Figs. 4a, c): while for σ = 1 half of the patients in the unit are colonizedRelative Effects of Barrier Precautions and Topical Antibiotics 2237
Fig. 4 pG = 0.2, pGL = 0.1, pj = 0.05 for j  = 0,G,GL. αSG = 0.5, αLS = 0.5, αSL = 0.2. Top: σ = 1,
bottom σ = 0.01. Left column: αGS = 1 (black), αGS = 0.1 (dark grey), αGS = 0.01 (light grey). The right
columns (ﬁgures (b) and (d)) show the mean of 1000 simulations, corresponding to αGS = 0.01, along with
the shaded area containing 90% of the simulations, and the result of a single simulation.
on average (regardless of the value of αGS), this number drops from 10 to 7 when σ = 0.01
and we reduce αGS from 1 to 0.01. The grey area (that contains 90% of all simulations),
shifts from 10±3 (not shown) for αGS = 1t o7±3f o rαGS = 0.01.
Figure 5 again shows that maintaining proper hygiene in the ICU is necessary if the
antibiotics are to have an effect at all: in Fig. 5a, when the cross-transmission is high,
antibiotics have no effect: only when σ is considerably reduced do the antibiotics have
an effect on the population level. This effect is now, due to the large proportion of newly
admitted individuals with intestinal colonization, considerable: on average, the number of
skin colonizations in the ICU is reduced from 17±3t o9±3.
When focusing on the averages, therefore, the deterministic and the stochastic model
echo the same message: antibiotic therapy as a means to reduce the prevalence of col-
onization in the ICU should only be used when a relatively high proportion of patients
are colonized in the intestines on admission and furthermore the barrier precautions have
already been applied to make sure that the occurrence of patient-to-patient transmission
in the ICU is as low as possible. Otherwise, the beneﬁts of antibiotic treatment may be
high on an individual level, but the effect on the population level will be negligible.
Due to the low number of patients in ICUs and the rapid turnover, stochastic effects
may lead to considerable ﬂuctuations in the prevalence of skin colonization in the ICU. In
10% ofthesimulationsthatfalloutofthegreyarea,wemayobservelongperiodsinwhich
the prevalence remains below average, even decreases, for long periods of time before it2238 Boldin et al.
Fig. 5 pG = 0.5, pGL = 0.2, pj = 0.05 for j  = 0,G,GL. αSG = 0.5, αLS = 0.5, αSL = 0.2. Top: σ = 1,
bottom σ = 0.01. Left column: αGS = 1 (black), αGS = 0.1 (dark grey), αGS = 0.01 (light grey). The right
columns (ﬁgures (b) and (d)) show the mean of 1000 simulations, corresponding to αGS = 0.01, along with
the shaded area containing 90% of the simulations, and the result of a single simulation.
increases again. In observing single runs (or, in real life, one intervention in one ICU) one
could, therefore, be tempted to believe that intestinal application of antibiotics has signif-
icant beneﬁts even in the case of low/intermediate admission of intestinal colonization.
The deterministic model and the ﬁgures representing the means of 1000 simulations show
that this is not the case: if such an intervention seems to be successful in an ICU, it may
very well be a matter of chance rather than due to real beneﬁts of antibiotic prophylaxis.
5. Discussion
Complex pathogen dynamics, small patient populations and rapid patient turnover make
the observation of the efﬁcacy of different infection control measures in ICUs very difﬁ-
cult. Barrier precautions and intestinal administration of topical antibiotics are two mea-
sures that can be applied to reduce the prevalence of antibiotic resistant pathogens. Yet,
prophylactic use of topical antibiotics is highly controversial (Bonten et al., 1996, 1998,
2001) as it may lead to increased occurrence of resistant strains. Moreover, different con-
trol measures are usually implemented simultaneously, precluding the evaluation of the
effects of individual measures. To amend for the lack of theoretical background in this
matter, we formulated a deterministic and a discrete time Markov chain model to describe
the dynamics of antibiotic resistant bacteria in ICUs. We have demonstrated that intestinalRelative Effects of Barrier Precautions and Topical Antibiotics 2239
application of nonabsorbable antibiotics, with the aim of reducing antibiotic resistance at
the population level, can only be effective when (i) a high percentage of newly admitted
patients is colonized in the intestines and (ii) cross-transmission rates in the ward are low.
Our ﬁndings thus represent a ﬁrm theoretical argument against the routine use of topical
antimicrobial prophylaxis for infection control.
Our study can be applied to several pathogens commonly found in ICUs, such as
Pseudomonasaeruginosa,MRSA,enterococciandentericGram-negativebacteria. Simul-
taneous colonization at multiple body sites with such pathogens is universal among ICU-
patients (Bontenetal., 1996).Pathogen dynamics,therefore, includes boththewithin-host
and patient-to-patient transmission. From a conceptual point of view, these colonization
sites can be divided in internal and external compartments, distinguished by the capacity
to act as a source for cross-transmission. The model used in this study was based on this
concept, with the skin as the representative for all body sites that can be contacted by
health care workers, and thus be a source for cross-transmission. For the internal com-
partments we chose the lungs and the intestinal tract.
Under the vocal cords, the respiratory tract is usually sterile. Colonization frequently
occurs in ICU-patients as the physiological defence mechanisms against aspirated mi-
croorganisms are breached because of intubation. Moreover, the commensal bacterial
ﬂora of the upper respiratory tract, susceptible to many antibiotics, rapidly disappears
after ICU-admission, partly because of antibiotics. Subsequently, the upper and lower res-
piratory tract become colonized with the typical hospital-acquired bacterial ﬂora, which is
often resistant to many antibiotics (e.g. Pseudomonas aeruginosa, Enterobacteriaceae and
MRSA). From the respiratory tract pathogens may reach the external compartment (where
they can contaminate health care workers hands) during patient care. Eradication of bac-
terial colonization in the oropharyngeal cavity (part of the upper respiratory tract) can
be achieved with topical antimicrobial agents (Bergmans et al., 2001). Yet, this approach
does not completely eradicate colonization of the lower respiratory tract. In our analyses
we therefore considered lung colonization as a constant source from where bacteria could
reach the external compartment.
The intestinal tract is considered the most abundant source of pathogens causing
hospital-acquired infections. As in the respiratory tract, the commensal bacterial ﬂora
that is susceptible to many antibiotics, is rapidly replaced after ICU-admission with the
typical hospital-acquired bacterial ﬂora. In contrast with the respiratory tract, however,
eradication of this ﬂora is achievable with nonabsorbable antibiotics.
Because of the constantly increasing prevalence of antibiotic resistance, prevention of
transmission of such pathogens becomes more and more important. Barrier precautions
are key in infection prevention in hospitals. In clinical practice, such measures include
optimal hand hygiene after patient contact, placing a patient in a single-bed room and
approaching the patient only when wearing gloves and gowns. Barrier precautions alone
have, however, frequently been insufﬁcient to prevent the spread of antibiotic resistant
pathogens and additional preventive measures are needed, especially in ICUs.
Eradication of bacterial colonization could be a very effective control measure. For
most antibiotic-resistant bacteria, colonization, once established, persists until patient dis-
charge from the ICU. After that, reestablishment of the commensal ﬂora occurs, possibly
because of reduced antibiotic selective pressure. Several eradication strategies have been
implemented, though frequently without success (Loeb et al., 2003). The concept of non-
absorbable antibiotics applied into the intestinal tract, usually through a nasogastric tube,2240 Boldin et al.
has met considerable enthusiasm (van Saene et al., 2003). It has been tested frequently
as part of SDD, in which intestinal decontamination is combined with oropharyngeal
decontamination and a short course of intravenous antibiotic prophylaxis. The primary
goal of SDD was to prevent the development of ICU-acquired respiratory tract infections.
After more than forty randomized trials evaluating the effects of SDD, there is strong
evidence that SDD indeed reduces incidences of ICU-acquired respiratory tract infec-
tions (van Saene et al., 2003). Moreover, ICU-survival among patients receiving SDD
increased according to three recent studies (de Jonge et al., 2003; de la Cal et al., 2005;
Krueger et al., 2002). The effects of SDD on the prevalence of antibiotic resistant bacteria,
however, are controversial: SDD enhanced preexisting high antibiotic resistant prevalence
levels (Lingnau et al., 1998), whereas SDD reduced such prevalence levels in units with
low baseline prevalences (de Jonge et al., 2003). It is generally assumed that the intestinal
component of SDD has the largest effect on increasing or decreasing unit-wide preva-
lence levels of antibiotic resistance. This assumption is supported by the reported effects
of topical antimicrobial prophylaxis, as in SDD, as a measure for controlling outbreaks
of antibiotic resistance (Brun-Buisson et al., 1989). Therefore, the use of SDD has been
advocated as a routine measure to control antibiotic resistance in ICUs.
Our ﬁndings, to some extent, support this concept. Yet, optimal use of barrier precau-
tions and a relatively high admission rate of intestinal carriage of resistant bacteria are
prerequisites for the efﬁcacy of intestinal decontamination. In most ICUs a considerable
part of the patients is directly admitted from the community (such as trauma patients) and
the admission prevalence of colonization with resistant bacteria will be low. To conclude,
the results of this study, therefore militate against the routine use of topical antimicrobial
prophylaxis for infection control.
Appendix A The deterministic model revisited
The aim of this part is to establish the number of equilibria of the system (1)a n dt h e i r
stability. But ﬁrst, we pay attention to the formulation of the model.
Let N0, NG, NS, NL, NGS, NGL, NSL, NGSL denote the sizes of the subpopulations in-
dicated by the indices. If the population sizes were large, we could describe the dynamics
with the following system of ODEs:
˙ N0 = λp0 −β(NS +NGS +NSL +NGSL)N0 −μN0,
˙ NG = λpG −β(NS +NGS +NSL +NGSL)NG −(αGS +μ)NG,
˙ NS = λpS +β(NS +NGS +NSL +NGSL)N0 −(αSG +αSL +μ)NS,
˙ NL = λpL −β(NS +NGS +NSL +NGSL)NL −(αLS +μ)NL,
˙ NGS = λpGS +β(NS +NGS +NSL +NGSL)NG −(αSL +μ)NGS
+αGSNG +αSGNS,
˙ NGL = λpGL −β(NS +NGS +NSL +NGSL)NGL −(αGS +αLS +μ)NGL,
˙ NSL = λpSL +β(NS +NGS +NSL +NGSL)NL −(αSG +μ)NSL
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˙ NGSL = λpGSL +β(NS +NGS +NSL +NGSL)NGL +(αLS +αGS)NGL
+αSLNGS +αSGNSL −μNGSL.
The total population size,
N(t)= N0(t)+NG(t)+NS(t)+NL(t)+NGS(t)+NGL(t)+NSL(t)
+NGSL(t)
changes according to the differential equation
˙ N = λ−μN
and so the equilibrium N∗ = λ
μ is globally asymptotically stable. If we denote
xj =
Nj
N∗,j ∈{ 0,G,S,L,GS,GL,SL,GSL},
I = xS +xGS +xLS +xGSL and σ =
λβ
μ we can indeed rewrite the system as (1).
To study the steady states of (1), we ﬁrst express
xj,j ∈{ 0,G,S,L,GS,GL,SL,GSL}
in terms of I∗ (the steady state values will be indicated by a superscript ∗).
We have
⎧
⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎨
⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎩
x∗
0 =
μp0
σI∗ +μ
,
x∗
G =
μpG
σI∗ +αGS +μ
,
x∗
L =
μpL
σI∗ +αLS +μ
,
x∗
GL =
μpGL
σI∗ +αGS +αLS +μ
,
(A.1a)
as the steady state values of four variables, and, using these, we can write the remaining
four as
⎧
⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎨
⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎩
x∗
S =
μpS
αSG +αSL +μ
+
σI∗
αSG +αSL +μ
x∗
0,
x∗
GS =
μpGS
αSL +μ
+
σI∗ +αGS
αSL +μ
x∗
G +
αSG
αSL +μ
x∗
S,
x∗
SL =
μpSL
αSG +μ
+
σI∗ +αLS
αSG +μ
x∗
L +
αSL
αSG +μ
x∗
S,
x∗
GSL = pGSL +
σI∗ +αLS +αGS
μ
x∗
GL +
αSL
μ
x∗
GS +
αSG
μ
x∗
SL,
(A.1b)
which are explicit expressions in terms of I∗ once we insert (A.1a).2242 Boldin et al.
The steady state value I∗ satisﬁes
I
∗ = x
∗
S +x
∗
GS +x
∗
SL +x
∗
GSL =: F(I
∗),
where x∗
S, x∗
GS, x∗
SL and x∗
GSL are given in (A.1). Hence, we need to investigate the ﬁxed
points of F.
After some manipulation we ﬁnd that
F(I)= p +
p0σI
σI+μ
+
pL(σI +αLS)
σI+αLS +μ
+
pG(σI +αGS)
σI+αGS +μ
+
pGL(σI +αGS +αLS)
σI+αGS +αLS +μ
,
where p = pS +pGS +pSL +pGSL and the function F has the following properties:
1. F(0) ≥ 0
2. F  (I) ≥ 0f o rI ≥ 0
3. limI→∞F(I)= 1a n d
4. F   (I) ≤ 0f o rI ≥ 0
These properties ensure that, when F(0)>0 the function F has a unique, strictly
positive ﬁxed point I∗. The system (1) then has a unique strictly positive steady state.
Once I∗ is determined, we can calculate the steady state values of all state variables using
(A.1).
Suppose now that F(0) = 0. If we assume that αGS > 0a n dαLS > 0t h e nF(0) = 0
precisely when all newly introduced individuals are susceptible. In this case the value of
F  (0) determines whether there will exist a nontrivial steady state. If F  (0) = σ
μ = R0 > 1
then we have a unique, strictly positive steady state and if R0 ≤ 1 then there is only the
trivial steady state.
What remains is the possibility that at least one of αGS,α LS equals zero. Let us only
consider the case αGS = 0,α LS > 0 (the other two options are treated in the same way).
Then F(0) = 0 precisely when p0 + pG = 1, that is, all newly introduced patients are
either not colonized at all or carry the bacteria in their gut. But since αGS = 0 they can
not spread the bacteria to their skin and we can treat individuals in x0, xG as a hetero-
geneous susceptible population. Hence, R0 = p0
σ
μ + pG
σ
μ = σ
μ = F  (0) and an endemic
equilibrium exists only when R0 > 1.
Let us now focus on the case when F(0)>0 and show that the (unique) equilibrium
is locally asymptotically stable. The same line of reasoning can in fact also be applied to
show the stability statements for the case F(0) = 0.
To this end let
x
∗ = (x
∗
0,x
∗
G,x
∗
S,x
∗
L,x
∗
GS,x
∗
GL,x
∗
SL,x
∗
GSL)
denote the (unique) equilibrium of (1). The Jacobi matrix evaluated in x∗ is denoted by J
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J =
⎛
⎜ ⎜
⎜ ⎜
⎜ ⎜
⎜ ⎜
⎜ ⎜
⎝
J1 0 −σx∗
0 0 −σx∗
0 0 −σx∗
0 −σx∗
0
0 J2 −σx∗
G 0 −σx∗
G 0 −σx∗
G −σx∗
G
σI∗ 0 J3 0 σx∗
0 0 σx∗
0 σx∗
0
00 −σx∗
L J4 −σx∗
L 0 −σx∗
L −σx∗
L
0 σI∗ +αGS σx∗
G +αSG 0 J5 0 σx∗
G σx∗
G
00 −σx∗
GL 0 −σx∗
GL J6 −σx∗
GL −σx∗
GL
00 σx∗
L +αSL σI∗ +αLS σx∗
L 0 J7 σx∗
L
00 σx∗
GL 0 σx∗
GL +αSL σI∗ +αLS +αGS σx∗
GL +αSG J8
⎞
⎟ ⎟
⎟ ⎟
⎟ ⎟
⎟ ⎟
⎟ ⎟
⎠
,
where
J1 =− (σI
∗ +μ), (A.2a)
J2 =− (σI
∗ +αGS +μ), (A.2b)
J3 = σx
∗
0 −αSG −αSL −μ, (A.2c)
J4 =− (σI
∗ +αLS +μ), (A.2d)
J5 = σx
∗
G −αSL −μ, (A.2e)
J6 =− (σI
∗ +αGS +αLS +μ), (A.2f)
J7 = σx
∗
L −αSG −μ, (A.2g)
J8 = σx
∗
GL −μ. (A.2h)
Let us deﬁne
S =
⎛
⎜
⎜ ⎜
⎜ ⎜
⎜ ⎜
⎜ ⎜
⎝
1 0000000
0 1000000
0 0100000
0 0010000
0 0001000
0 0000100
0 0000010
00−10−10−11
⎞
⎟
⎟ ⎟
⎟ ⎟
⎟ ⎟
⎟ ⎟
⎠
and calculate K = S−1JS.W eo b t a i n
K =
⎛
⎜
⎜ ⎜
⎜ ⎜
⎜ ⎜
⎜ ⎜
⎜ ⎜
⎜ ⎜
⎜
⎝
K1 0 0 0 000 −σx∗
0
0 K2 0 0 000 −σx∗
G
σI∗ 0 K3 0 000 σx∗
0
000 K4 000 −σx∗
L
0 σI∗ +αGS αSG 0 K5 00 σx∗
G
0000 0 K6 0 −σx∗
GL
00 αSL σI∗ +αLS 00 K7 σx∗
L
σI∗ σI∗ +αGS 0 σI∗ +αLS 0 σI∗ +αLS +αGS 0 K8
⎞
⎟
⎟ ⎟
⎟ ⎟
⎟ ⎟
⎟ ⎟
⎟ ⎟
⎟ ⎟
⎟
⎠
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where
Ki = Ji for i = 1,2,4,6( A . 3 )
and
K3 =− (αSG +αSL +μ), (A.4a)
K5 =− (αSL +μ), (A.4b)
K7 =− (αSG +μ), (A.4c)
K8 =− μ+σ(x
∗
0 +x
∗
G +x
∗
L +x
∗
GL). (A.4d)
Now,itisclearfromtheformof K that K3, K5 and K7 areeigenvaluesof K (andtherefore
of J,s i n c eK and J are related by a similarity transformation) and from (A.4a–A.4c)t h a t
they are strictly negative. Our aim now is to show that all other eigenvalues of K have
negative real parts as well. In fact, we will see that all the eigenvalues of K are real.
So let φ be an eigenvalue of K and let vT = (v1,...,v 8) be a corresponding eigenvec-
tor. We have the following relations:
0 = (K1 −φ)v1 −σx
∗
0v8, (A.5a)
0 = (K2 −φ)v2 −σx
∗
Gv8, (A.5b)
0 = (K4 −φ)v4 −σx
∗
Lv8, (A.5c)
0 = (K6 −φ)v6 −σx
∗
GLv8, (A.5d)
0 = σI
∗v1 +(σI
∗ +αGS)v2 +(σI
∗ +αLS)v4
+(σI
∗ +αLS +αGS)v6 +(K8 −φ)v8 (A.5e)
and
0 = σI
∗v1 +(K3 −φ)v3 +σx
∗
0v8, (A.5f)
0 = (σI
∗ +αGS)v2 +αSGv3 +(K5 −φ)v5 +σx
∗
Gv8, (A.5g)
0 = αSLv3 +(σI
∗ +αLS)v4 +(K7 −φ)v7 +σx
∗
Lv8. (A.5h)
We ﬁrst consider the following situation:
CASE 1. αGS > 0, αLS > 0, αGS  = αLS
Let us ﬁrst see that in this case the spectrum of K cannot contain Ki for i ∈{ 1,2,4,6}.
We show this by contradiction. Suppose that φ = K1.S i n c ex∗
0  = 0, K1  = K2, K4,
K6 and I∗  = 0 we see from (A.5a–A.5e)t h a tv1 = v2 = v4 = v6 = v8 = 0 and then from
(A.5f–A.5h)t h a ta l s ov3 = v5 = v7 and so v = 0, which cannot be the case since v is an
eigenvector.
In the same way we can see that neither of K2, K4, K6 lies in the spectrum of K.W e
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(A.5e)t h a tv8 = 0o r
σ2I∗x∗
0
K1 −φ
+
σ(σI∗ +αGS)x∗
G
K2 −φ
+
σ(σI∗ +αLS)x∗
L
K4 −φ
+
σ(σI∗ +αGS +αLS)x∗
GL
K6 −φ
+K8 −φ = 0. (A.6)
Let us ﬁrst assume that v8  = 0. Then, using (A.2a), (A.2b), (A.2d), (A.2f), (A.3)a n d
(A.4d) we can rewrite (A.6)a s
(φ +μ)
 
σx∗
0
−K1 +φ
+
σx∗
G
−K2 +φ
+
σx∗
L
−K4 +φ
+
σx∗
GL
−K6 +φ
 
−(φ +μ) = 0.
(A.7)
Hence, either φ =− μ<0, or
σx∗
0I∗
−K1 +φ
+
σx∗
GI∗
−K2 +φ
+
σx∗
LI∗
−K4 +φ
+
σx∗
GLI∗
−K6 +φ
−I
∗ = 0. (A.8)
Let us now write φ in (A.8)a sφ = ν +iκ. Separating the real and the imaginary compo-
nent, we see that necessarily κ = 0o r
σx∗
0
(−K1 +ν)2 +κ2 +
σx∗
G
(−K2 +ν)2 +κ2 +
σx∗
L
(−K4 +ν)2 +κ2
+
σx∗
GL
(−K6 +ν)2 +κ2 = 0, (A.9)
and since the steady state values of x∗
0, x∗
G, x∗
L, x∗
GL are positive we conclude that κ = 0.
Suppose now that ν = φ ≥ 0. We can then estimate the left hand side of (A.8)a s
follows
···<
σx∗
0I∗
−K1
+
σx∗
GI∗
−K2
+
σx∗
LI∗
−K4
+
σx∗
GLI∗
−K6
−I
∗
<
σp0I∗
−K1
+
σp∗
GI∗
−K2
+
σpLI∗
−K4
+
σpGLI∗
−K6
−I
∗
<p+
p0σI∗
−K1
+
pG(σI∗ +αGS)
−K2
+
pL(σI∗ +αLS)
−K4
+
pGL(σI∗ +αGS +αLS)
−K6
−I
∗
= F(I
∗)−I
∗ = 0,
where we have used in the second line that x∗
j <p j for j ∈{ 0,G,L,GL} and in the last
that I∗ is a ﬁxed point of F.
Hence, in order for φ to be a solution of (A.8), φ has to be negative.
Now, all that remains to consider in this ﬁrst case are the eigenvalues of K for which
the corresponding eigenvector is such that v8 = 0. Since we have already established that2246 Boldin et al.
φ  = K1, K2, K4, K6 we obtain from (A.5a–A.5d)t h a ta l s ov1 = v2 = v4 = v6 = 0. We can
then rewrite (A.5f–A.5h)a s
0 = (K3 −φ)v3, (A.10a)
0 = αSGv3 +(K5 −φ)v5, (A.10b)
0 = αSLv3 +(K7 −φ)v7 (A.10c)
and observe that, since not all three of v3, v5, v7 can be zero, the remaining three eigen-
values K are K3, K5 and K7 (as we have already observed in the beginning).
Since K3, K5 and K7 are all strictly negative we have now shown that in the case when
αGS > 0, αLS > 0a n dαGS  = αLS all the eigenvalues of K are real and strictly negative and
so the steady state x∗ is locally asymptotically stable.
To complete the proof, we need to check what happens when the assumptions of the
Case 1 are not met. This can happen in the following ways:
CASE 2. αGS > 0, αLS > 0, αGS = αLS
CASE 3. αGS = 0, αLS > 0
CASE 4. αGS > 0, αLS = 0
CASE 5. αGS = 0, αLS = 0
Since all these cases are handled in a similar manner, we shall give details for only one of
them, namely, Case 2.
In the same way as before, we observe that K1 and K6 cannot be in the spectrum of K.
In this case, however K2(= K4) can be an eigenvalue and we will see that this necessarily
is the case.
Let us ﬁrst consider an eigenvalue of K,s a yφ, such that φ  = K2. We can then ex-
press v1, v2, v4 and v6 in terms of v8 and just as in Case 1 obtain that v8 = 0, φ =− μ
or that φ satisﬁes (A.8). Since the conclusion from Case 1, that in the latter case neces-
sarily φ<0, relied nowhere on the fact that αGS  = αLS we can carry it over right away to
Case 2. Note however that, since K2 = K4, we obtain a polynomial of degree 3 and hence
three (strictly negative) roots. The ‘missing’ eigenvalue can only be equal to K2,w h i c hi s
strictly negative and so we again conclude that x∗ is locally asymptotically stable.
This completes the proof.
Appendix B Additional ﬁgures
In Fig. B.1, we show the results of the same experiment as described in Section 4.1, only
this time with αLS = 1
15.
Figures B.2 and B.3 show the effects of reducing the proportion of individuals that are
colonized on the skin already on admission. We begin at the right end point of the p-axis,
with a certain starting distribution {pj}, j ∈{ 0,G,S,L,GS,GL,SL,GSL}. Reductions in
p = pS + pGS + pSL + pGSL are uniform in the four compartments S, GS, SL, GSL and
yield a uniform increase in 0, G, L, GL.Relative Effects of Barrier Precautions and Topical Antibiotics 2247
Fig. B.1 The endemic level of skin colonizations plotted as a function of αGS. In all three ﬁgures μ = 1
10,
αLS = 1
15 and, from the top to the bottom, σ = 1
2, 1
5, 1
8, 1
10, 1
20, 1
50,0 .I n( a )pj = 0.05 for j  = 0,
(b) pG = 0.2, pGL = 0.1, pj = 0.05 for j  ={ 0,G,GL} a n di n( c )pG = 0.5, pGL = 0.2, pj = 0.05 for
j  ={ G,GL}.
Fig. B.2 In all three ﬁgures σ = 0.1 and, from top to bottom: αGS = 1, 0.8, 0.6, 0.4, 0.2, 0. The starting
probabilities at the right end point of the p-axis are (a) pj = 0.05 for j  = 0, (b) pG = 0.2, pGL = 0.1,
pj = 0.05 for j  ={ 0,G,GL} a n di n( c )pG = 0.5, pGL = 0.2, pj = 0.05 for j  ={ G,GL}.
Fig. B.3 In all three ﬁgures αGS = 0.5 and, from top to bottom: σ = 0.1, 0.08, 0.06, 0.04, 0.02, 0.
The starting probabilities at the right end point of the p-axis are (a) pj = 0.05 for j  = 0, (b) pG = 0.2,
pGL = 0.1, pj = 0.05 for j  ={ 0,G,GL} a n di n( c )pG = 0.5, pGL = 0.2, pj = 0.05 for j  ={ G,GL}.2248 Boldin et al.
References
Bergmans, D.C., Bonten, M.J.M., Gaillard, C.A., Palling, J.C., van der Geest, S., van Tiel, F.H., Beysens,
A.J., de Leeuw, P.W., Stobberingh, E.E., 2001. Prevention of ventilator-associated pneumonia by oral
decontamination: a prospective, randomized, double-blind, placebo-controlled study. Am. J. Respir.
Crit. Care Med. 163(3), 382–388.
Bonten, M.J.M., Bergmans, D.C., Ambergen, A.W., de Leeuw, P.W., van der Geest, S., Stobberingh, E.E.,
Gaillard, C.A., 1996. Risk factors for pneumonia, and colonization of respiratory tract and stomach in
mechanically ventilated ICU patients. Am. J. Respir. Crit. Care Med. 154, 1339–1346.
Bonten, M.J.M., Slaughter, S., Ambergen, A.W., Hayden, M.K., van Voorhis, J., Nathan, C., Weinstein,
R.A., 1998. The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an
important infection control variable. Arch. Intern. Med. 158(10), 1127–1132.
Bonten, M.J.M., Austin, D.J., Lipsitch, M., 2001. Understanding the spread of antibiotic resistant
pathogens in hospitals: mathematical models as tools for control. Clin. Infect. Dis. 33, 1739–1746.
Brun-Buisson, C., Legrand, P., Rauss, A., Richard, C., Montravers, F., Besbes, M., Meakins, J.L., Soussy,
C.J., Lemaire, F., 1989. Intestinal decontamination for control of nosocomial multiresistant gram-
negative bacilli. Study of an outbreak in an intensive care unit. Ann. Intern. Med. 110(11), 873–881.
de Jonge, E., Schultz, M., Spanjaard, L., Bossuyt, P.P.M., Vroom, M.B., Dankert, J., Keseciglou, J., 2003.
Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria
in intensive care: a randomised controlled trial. Lancet 362(9389), 1011–1016.
de la Cal, M.A., Cerda, E., Garcia-Hierro, P., van Saene, H.K., Gomez-Santos, D., Negro, E., Lorente,
J.A., 2005. Survival beneﬁt in critically ill burned patients receiving selective decontamination of the
digestive tract: a randomized, placebo-controlled, double-blind trial. Ann. Surg. 241(3), 424–430.
Diekmann, O., Heesterbeek, J.A.P., 2000. Mathematical Epidemiology of Infectious Diseases. Wiley Se-
ries in Mathematical and Computational Biology. Wiley, Chichester. Model building, analysis and
interpretation.
Krueger, W.A., Lenhart, F.P., Neeser, G., Ruckdeshel, G., Schreckhase, H., Eissner, H.J., Forst, H., Eckart,
J., Peter, K., Unertl, K.E., 2002. Inﬂuence of combined intravenous and topical antibiotic prophylaxis
on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients:
a prospective, stratiﬁed, randomized, double-blind, placebo-controlled clinical trial. Am. J. Respir.
Crit. Care Med. 166(8), 1029–1037.
Lingnau, W., Berger, J., Javorsky, F., Lejeune, P., Mutz, N., Benzer, H., 1997. Selective intestinal deconta-
mination in multiple trauma patients: prospective, controlled trial. J. Trauma 42(4), 687–694.
Lingnau, W., Berger, J., Javorsky, F., Fille, M., Allerberger, F., Benzer, H., 1998. Changing bacterial ecol-
ogy during a ﬁve-year period of selective intestinal decontamination. J. Hosp. Infect. 39(3), 195–206.
Loeb,M.,Main,C.,Walker-Dilks,C.,Eady,A.,2003.Antimicrobialdrugsfortreatingmethicillin-resistant
staphylococcus aureus colonization. Cochrane Database Syst. Rev. 4, CD003340.
van Saene, H.K., Petros, A.J., Ramsay, G., Baxby, D., 2003. All great truths are iconoclastic: selective
decontamination of the digestive tract moves from heresy to level 1 truth. Intensive Care Med. 29(5),
677–690.
Verwaest, C., Verhaegen, J., Ferdinande, P., Schetz, M., van der Berghe, G., Lauwers, P., 1997. Random-
ized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in
a multidisciplinary intensive care unit. Crit. Care Med. 25(1), 63–71.